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In Brief
Olea et al. select mirror-image RNA
molecules, composed of the non-natural
L-isomer, for their ability to bind and
inhibit RNase, an enzyme that rapidly
degrades natural RNA. This was
accomplished by selecting natural RNAs
that bind the full-length, non-natural
isomer of RNase then reversing the mirror
to enable L-RNA to protect its natural
counterpart.
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L-RNA aptamers were developed that bind to bar-
nase RNase and thereby inhibit the function of the
enzyme. These aptamers were obtained by first car-
rying out in vitro selection of D-RNAs that bind to the
full-length synthetic D-enantiomer of barnase, then
reversing the mirror and preparing L-RNAs of iden-
tical sequence that similarly bind to natural L-bar-
nase. The resulting L-aptamers bind L-barnase with
an affinity of 100 nM and function as competitive
inhibitors of enzyme cleavage of D-RNA substrates.
L-RNA aptamers are resistant to degradation by ribo-
nucleases, thus enabling them to function in biolog-
ical samples, most notably for applications in molec-
ular diagnostics and therapeutics. In addition to the
irony of using RNA to inhibit RNase, L-RNA aptamers
such as those described here could be used to mea-
sure the concentration or inhibit the function of
RNase in the laboratory or in biological systems.
INTRODUCTION
Numerous RNA aptamers have been obtained that bind small-
molecule and protein targets with high affinity and high speci-
ficity (Gold et al., 1995; Klussmann, 2006). Unmodified RNAs
are rapidly degraded by ribonucleases that are ubiquitous in
biological samples. The half-life of RNA in human serum, for
example, is only a few seconds (Tsui et al., 2002). Thus, if
RNA aptamers are to be applied in a biological context they
must be modified with nuclease-resistant nucleotide analogs,
such as 20-O-methyl nucleotides (Keefe and Cload, 2008;
Wang et al., 2011). These modifications, unless built in from
the start of an aptamer selection, can potentially alter binding
affinity, thus requiring further optimization to accommodate the
modifications.
An alternative approach utilizes L-RNA, the enantiomeric
counterpart of natural D-RNA. Unlike D-RNA, L-RNA is not
degraded by biological ribonucleases. L-RNA aptamers, termed
Spiegelmers, are generated by selecting natural D-RNAs against
the enantiomer of the desired target (Klussmann et al., 1996;
Nolte et al., 1996). Once a D-aptamer is obtained, an L-RNA ap-
tamer of the same sequence can be prepared and used to bind
the natural target in amirror-identical fashion. Several L-RNA ap-
tamers are currently in phase II human clinical trials (SchwoebelChemistry & Biology 22, 1437–144et al., 2013; Hoellenriegel et al., 2014), and an L-aptamer has
been engineered for the quantitative analysis of ligand concen-
trations in human serum (Olea et al., 2012).
To date, L-RNA aptamers only have been selected against
small molecules (Klussmann et al., 1996; Nolte et al., 1996), pep-
tides (Maasch et al., 2010), chemokines (Eulberg et al., 2008),
and small structured D-RNAs (Sczepanski and Joyce, 2013).
None have been selected against a complete functional enzyme,
largely because of the difficulty in synthesizing the full-length
enantiomeric protein. Proteins are instead targeted for selection
by preparing a small peptide that corresponds to an epitope
within the overall protein. However, there are two advantages
in carrying out an aptamer selection using the entire protein.
First, it ensures that the aptamer will bind to the intact protein
as well as the chosen epitope. Second, it increases the likelihood
that any inhibition of protein function that occurs as a conse-
quence of binding will apply in the fully native context.
The goal of the present study was to generate an L-RNA ap-
tamer against an intact protein enzyme. Barnase, the well-stud-
ied RNase from Bacillus amyloliquefaciens, was chosen as the
target because it provides a case whereby a D-RNA aptamer
would be ineffective due to degradation of D-RNA by the target
enzyme. The complete D-enantiomer of barnase was prepared
by chemical synthesis and allowed to fold into its active confor-
mation. The D-form of the enzyme was used as the target to
select D-RNA aptamers with high affinity for barnase. As is
inevitably the case, an L-RNA version of these aptamers binds
to natural L-barnase in the same manner. Aptamer binding to
the enzyme results in corresponding inhibition of enzyme func-
tion, thereby enabling the L-aptamer to block the ability of RNase
to degrade D-RNA.RESULTS
Full-length D-barnase, containing 110 amino acids, was pre-
pared by solid-phase synthesis. Two half-length polypeptides
were prepared, then joined by native chemical ligation (Dawson
et al., 1994, 1997) to yield the complete protein. The lysine at
position 49 was replaced by cysteine to provide a site for
derivatization with biotin, which enabled immobilization of the
protein on streptavidin. The site of biotinylation is on the opposite
face of the enzyme relative to the RNA binding cleft, thus pre-
senting the active site of the enzyme as a potential target for ap-
tamer binding (Figure 1). The full-length D-barnase was analyzed
by electrospray ionization mass spectrometry (ESI-MS), which
gave an observed mass of 12,357 ± 1 Da, compared with a
calculated mass of 12,357.8 Da (Figure S1A).1, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1437
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Figure 1. Structure of Barnase
X-Ray crystal structure of barnase (Buckle et al.,
1993) showing the site of lysine to cysteine substi-
tution that enables derivatization with biotin (en-
circled B). The RNA binding cleft is on the opposite
face (see also Figure S1).D-Barnase was folded by dilution from 6 M guanidine hydro-
chloride and assayed for activity using an L-RNA oligonucleotide
substrate. The synthetic D-enzyme maintains the natural prefer-
ence for cleavage at the 30-side of guanylate residues, but with
reciprocal chiral specificity for L-RNA (Figure 2A). Contrary to a
recently published report (Vinogradov et al., 2015), there was
no detectable cleavage of D-RNA by D-barnase, which made it
possible to carry out in vitro selection of D-RNAs that bind D-bar-
nase and are then amplified using biological polymerases. To
enable this selection procedure we conjugated a biotin moiety,
linked via polyethylene glycol to maleimide, at position Cys-49
of D-barnase. The composition of the resulting biotinylated
enzyme was confirmed by ESI-MS (Figure S1B).
Aptamers for D-barnase were obtained by in vitro selection
starting from a library of 5 3 1014 D-RNA molecules, each con-
taining a central region of 35 random-sequence nucleotides,
flanked by fixed primer binding sites (Figure S2A). Selection for
D-barnase aptamers was carried out in the presence of 25 mM
MgCl2 and 100 mM NaCl at pH 8.0 and 23
C. The RNA pool
(1 mM) was first incubated with streptavidin-coated magnetic
beads for 30 min to capture materials that bound to the beads
in the absence of barnase. Then the supernatant was withdrawn
and mixed with 1 mM D-barnase, incubated for 30 min, and
applied to fresh streptavidin-coated beads to capture barnase
and any RNAs that were bound to the protein. After 15 min
the beads were washed four times with 1 ml of the same binding
solution. Then the bound RNAs were eluted with 25 mM NaOH
and 1 mM EDTA, reversed transcribed, and PCR amplified.
The resulting double-stranded DNAs were transcribed to
generate an enriched pool of selected RNAs. This procedure
was repeated for seven rounds. Individual clones were isolated
from the population following the fifth and seventh rounds and
assayed for their ability to inhibit the activity of D-barnase
(Figure S2B).
Two clones, referred to as 5-4 and 7-3, were chosen for further
analysis based on their frequency of occurrence (after rounds
five and seven, respectively) and the ability of the corresponding
L-RNAs to inhibit L-barnase (Figure 2B). D-5-4 RNA was trun-
cated at both its 50 and 30 ends and engineered to contain a
stable GUAA tetraloop within the distal stem, resulting in the
minimized constructD-5-4t (Figure 3).D-5-4t contains 45 nucle-
otides and consists of two stem regions joined by a double inter-1438 Chemistry & Biology 22, 1437–1441, November 19, 2015 ª2015 Elsevier Ltd All rightsnal bulge loop. The full-length D-7-3 RNA
has greater ability to inhibit D-barnase
compared with various truncation versions
that were tested, and therefore was left
intact (Figure 3). It contains 72 nucleotides
and also consists of two stem regions
joined by a double internal bulge loop.
The binding affinity of D-5-4t and D-7-3
for D-barnase was determined using an
electrophoretic mobility shift assay, which gave apparent KD
values of 150 and 73 nM, respectively (Figure 4A). The corre-
sponding L-RNA aptamers were prepared by chemical synthesis
and gel purified. The recombinant wild-type L-barnase was
expressed and purified from Escherichia coli as described
previously (Hartley and Rogerson, 1972; see also Supplemental
Experimental Procedures), thenanalyzedbyESI-MS (FigureS1C).
In-line probing, based on partial hydrolysis under non-
denaturing conditions (Soukup and Breaker, 1999), was car-
ried out for both L-RNA aptamers in either the absence or
presence of saturating concentrations (12 mM) of L-barnase
(see Supplemental Experimental Procedures). This was done
to identify nucleotides that interact with the protein, resulting
in their relative protection from hydrolysis (Figure 3). For L-
5-4t, both sides of the internal bulge loop were substantially
protected from hydrolysis in the presence of barnase, but
there was no significant protection within the two flanking
stems. For L-7-3, there was substantial protection within
the proximal portion of the distal stem and adjoining 30-
portion of the internal bulge loop, but no significant protec-
tion within the proximal stem or the distal portion of the
distal stem.
In the absence of the L-RNA aptamers, the observed rate of
cleavage by L-barnase of a short, unstructured D-RNA substrate
was 0.33 min1. Under the conditions of the assay, which em-
ployed 0.125 nM barnase and 0.5 mM RNA at pH 8.0 and 23C,
the RNA substrate was completely degraded within 15 min.
Various concentrations of L-5-4t and L-7-3 were added to the
mixture to determine an IC50 value for their inhibition of L-bar-
nase activity (see Supplemental Experimental Procedures).
Both aptamers were found to be effective inhibitors, with IC50
values of 190 and 160 nM, respectively (Figure 4B). This
pales in comparison, however, with the subpicomolar inhibition
exhibited by barstar (Hartley, 1993), a bacterial protein that
coevolved with barnase. At a saturating concentration of 2 mM
L-RNA aptamer, the D-RNA substrate was not fully degraded
until 12 hr, corresponding to a 40- to 50-fold increase in sub-
strate half-life compared with the absence of the aptamer (Fig-
ure S4A). Neither L-RNA aptamer, even at 20 mM concentration,
exhibited detectable inhibition of either RNase A or RNase T1
(Figure S3), demonstrating the specificity of these aptamers for
L-barnase.reserved
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Figure 2. Inhibition ofBarnaseActivity by theSelectedRNAAptamers
(A) D-Barnase cleavage of 50-fluorescein-labeled L-RNA substrate, having the
sequence 50-GAUAGGUAG-30, is inhibited by the population of D-RNAs ob-
tained after the fifth round of selection (R5), but not by the starting population
(R0). Cleavage occurs at the 30 side of G residues, resulting in 50-labeled
products corresponding to GAUAGG, GAUAG, and G. Reaction conditions:
either none (–) or 20 mM D-RNA population, 25 nM D-barnase, 0.5 mM sub-
strate, 25 mM MgCl2, 100 mM NaCl, 50 mM EPPS (pH 8.0), and 0.1% Triton,
incubated at 23C for 1 min. Unreacted substrate (M) is shown on the left.
(B) L-Barnase cleavage of 50-fluorescein-labeled D-RNA substrate, having the
same sequence as above, is inhibited by L-5-4t and L-7-3, but not by a 55mer
control L-RNA of unrelated sequence (U) (see also Figure S3). Reaction con-
ditions as above, but with either none () or 10 mM 50-hexachloro-fluorescein-
labeled L-RNA (seen as the slow-migrating bands in the denaturing 15%
polyacrylamide gel) and 0.25 nM L-barnase, incubated for 5 min. Unreacted
substrate (M) and substrate that was subject to partial alkaline hydrolysis (OH)
are shown on the left.
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Figure 3. Sequence and Predicted Secondary Structure of Barnase
Aptamers
Red circles indicate nucleotide positions that are relatively protected against
hydrolytic cleavage in the aptamer-barnase complex compared with the ap-
tamer in isolation. Increasing color intensity corresponds to increasing levels of
protection. Boxes indicate nucleotide positions with enhanced susceptibility
to hydrolysis in the aptamer-barnase complex.
See also Figure S2.All of the clones that were isolated following the in vitro selec-
tion process were found to inhibit barnase activity (Figure S2B).
This may be a result of electrostatic interactions between theChemistry & Biology 22, 1437–144anionic RNA aptamer and the cationic substrate binding cleft
of barnase (Figure 1). The active site of barnase is dominated
by positive charges, with three basic residues that guide the
interaction with the negatively charged RNA substrate (Mauguen
et al., 1982; Baudet and Janin, 1991). In support of this hypoth-
esis, both the L-5-4t and L-7-3 aptamers were found to exhibit
strictly competitive inhibition kinetics in the barnase-catalyzed
RNA-cleavage reaction (Figures S4B and S4C). While these re-
sults do not necessarily exclude binding of the aptamers at an
allosteric site on the free enzyme that prevents substrate bind-
ing, it seems more likely that the L-RNA aptamers and D-RNA
substrate compete for a common site. It would have been diffi-
cult to capture this interaction if the selection had been carried
out using a peptide fragment rather than the intact protein,1, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1439
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Figure 4. Binding and Inhibition of Barnase by Aptamers 5-4t and
7-3
Aptamer 5-4t is shown in black and aptamer and 7-3 in gray.
(A) Saturation plot for binding of the D-aptamers to D-barnase, as determined
by an electrophoretic mobility shift assay. Data were obtained in triplicate and
fitted to the equation Fbound = Fbound-max {[barnase]/(KD + [barnase])}.
(B) Rate of L-barnase cleavage of 0.2 mM D-RNA substrate, having the
sequence 50-UUGAUAGGUAGU-30, measured in the presence of various
concentrations of L-aptamer (see also Figure S4). Data were obtained in
triplicate and fitted to the equation kobs = {kobs-max (e
–a,[aptamer])} + kobs-min,
where kobs-max is the observed rate in the absence of aptamer and kobs-min is
the calculated rate at infinite aptamer concentration. Error bars represent the
standard deviation about the mean.especially because the active site of barnase is formed by multi-
ple epitopes that come together to form the substrate binding
cleft (Buckle et al., 1993).
DISCUSSION
The generation of L-RNA aptamers that bind biological proteins
requires selecting against a synthetic enantiomer of the desired
target. Previous efforts to develop such aptamers have em-
ployed peptides or peptide epitopes within the larger protein.
However, intact folded proteins present functionally relevant ter-
tiary epitopes that may not be captured by protein fragments,
and therefore provide a greater opportunity to generate ap-
tamers that can modulate protein function.
Despite having identical chemical composition as its natural
biological counterpart, L-RNA is orthogonal to biological systems.
This point was emphatically demonstrated here by choosing1440 Chemistry & Biology 22, 1437–1441, November 19, 2015 ª2015biological RNase as the target for in vitro selection of enantiomeric
RNA aptamers. The inhibition of specific ribonucleases may be
useful in deducing their function in both normal and diseased tis-
sues, most notably in cancer and inflammatory conditions (Kim
and Lee, 2009; Sun et al., 2013). Ongoing efforts to push the limits
of the chemical synthesis of D proteins, most recently to 312
residues (Weinstock et al., 2014), will make available additional
protein targets for the in vitro selection of L-RNA aptamers.
Suchmoleculesmay havebroader applications inmolecular diag-
nostics and therapeutics.
SIGNIFICANCE
Although biology is overwhelmingly homochiral, chemical
biologists are free to play on both sides of the mirror. Previ-
ous studies have led to the synthesis of functional proteins
and nucleic acids of opposite handedness compared with
their biological counterparts. Mirror-image aptamers that
bind to biological macromolecules in a cross-chiral fashion
have been obtained by in vitro selection. Here, for the first
time, a mirror-image aptamer is raised against an entire
enzyme, which necessitated the total synthesis of the non-
biological enantiomer of that enzyme. Barnase RNase was
chosen as the target because of the impossibility of target-
ing this molecule with biological D-RNA. By employing the
entire enzyme in its properly folded state, there was a high
likelihood that the selected L-RNA aptamers would inhibit
RNase function, which turned out to be the case. Two
distinct aptamer motifs were identified, each with an affinity
of100 nM for barnase and a corresponding ability to inhibit
the enzyme’s catalytic activity. Although RNase wins the
battle against biological D-RNA, L-RNA aptamers can turn
the tables and protect their enantiomeric counterparts
from RNase degradation.
EXPERIMENTAL PROCEDURES
Preparation of D-Barnase
The D-enantiomer of barnase K49C was synthesized using in situ neutraliza-
tion cycles for Boc-protected solid-phase peptide synthesis (Schno¨lzer
et al., 1992) and native chemical ligation (Dawson et al., 1994) of two polypep-
tides, as described previously (Dawson et al., 1997). See Supplemental Exper-
imental Procedures for synthetic methods and protein purification protocol.
In Vitro Selection
The starting library was prepared by synthesizing a DNA template containing
35 random-sequence nucleotides flanked by fixed primer binding sites (Fig-
ure S2A), which was made double stranded by primer extension, then tran-
scribed to generate a pool of 5 3 1014 corresponding RNAs. One nmol of
pool RNAs was incubated in a 1-ml volume containing 100 mM NaCl,
50 mM N-(2-hydroxyethyl)-piperazine-N0-3-propane sulfonic acid (EPPS) (pH
8.0), and 0.1% Triton at 70C for 2 min, then cooled on ice for 2 min. Then a
200-ml volume containing 2 mg of streptavidin resin, which had been pre-
blockedwith 1mg/ml tRNA and 25mMMgCl2, was added and allowed to incu-
bate at 23C for 30 min. The resin was captured magnetically, removing any
RNAs that had bound to it directly. Next 1 mM biotinylated D-barnase was
added, the solution was incubated at 23C for 15 min, and the protein and
any associated RNAs were captured on 8 mg (800 ml) of streptavidin resin,
as above. The resin was washed with 4 3 1-ml volumes of 25 mM MgCl2,
100 mM NaCl, 50 mM EPPS (pH 8.0), and 0.1% Triton, then the RNA
was eluted with 25 mM NaOH and 1 mM EDTA, neutralized with 0.5 M Tris-
HCl, reverse transcribed, and amplified by PCR. The amplified DNA wasElsevier Ltd All rights reserved
transcribed using T7 RNA polymerase, and the resulting RNAs were gel puri-
fied and used to begin the next round of in vitro selection. The volume of incu-
bation was reduced 4-fold in the subsequent rounds.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2015.09.017.
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